| |
| |
|
| Insider
Information: |
Kidron Nadav |
| Relationship: |
President and CEO, Dir... |
| City: |
Jerusalem |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,781,098 |
|
|
Indirect Shares
|
126,000 |
|
|
| Direct
Value |
$4,185,580 |
|
|
|
Indirect Value
|
$296,100 |
|
|
| Total
Shares |
1,907,098 |
|
|
| Total
Value |
$4,481,680 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -3.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oramed Pharmaceuticals Inc |
ORMP |
President and CEO, Dir... |
2024-01-04 |
1,781,098 |
2024-01-04 |
126,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
329,000 |
1,781,098 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
1,452,098 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2023-04-17 |
4 |
A |
$0.00 |
$0 |
D/D |
279,000 |
1,332,098 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2023-03-16 |
4 |
B |
$2.04 |
$53,014 |
I/I |
26,000 |
126,000 |
2.66 |
% |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2022-08-01 |
4 |
D |
$8.36 |
$105,595 |
D/D |
(12,631) |
1,078,098 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
160,000 |
1,090,729 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2022-01-03 |
4 |
D |
$13.89 |
$677,165 |
D/D |
(48,752) |
887,729 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
213,000 |
950,729 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2022-01-03 |
4/A |
D |
$13.89 |
$677,165 |
D/D |
(48,752) |
867,729 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2022-01-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
213,000 |
930,729 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2021-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
766,481 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2021-12-28 |
4 |
D |
$12.98 |
$411,829 |
D/D |
(31,728) |
786,481 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2021-12-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
818,209 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2021-08-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
100,000 |
838,209 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
748,573 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2021-08-09 |
4/A |
AS |
$20.11 |
$4,423,144 |
D/D |
(220,000) |
738,209 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2021-08-09 |
4 |
AS |
$20.11 |
$4,423,144 |
D/D |
(220,000) |
648,573 |
0 |
% |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2018-07-11 |
4 |
B |
$5.92 |
$722 |
D/D |
122 |
958,209 |
3.15 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2018-07-10 |
4 |
S |
$5.98 |
$365 |
D/D |
(61) |
958,087 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2016-05-12 |
4 |
B |
$6.90 |
$6,953 |
D/D |
1,000 |
958,148 |
3.15 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2015-05-12 |
4 |
B |
$6.55 |
$3,962 |
D/D |
600 |
957,148 |
3.15 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2015-03-19 |
4 |
B |
$3.92 |
$6,292 |
D/D |
1,600 |
956,548 |
3.15 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2015-03-18 |
4 |
B |
$3.78 |
$3,790 |
D/D |
1,000 |
954,948 |
3.15 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2015-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
79,848 |
953,948 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
President and CEO |
• • • |
2014-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
9,788 |
874,100 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
